Latest Novo Holdings A/S Stock Portfolio
$1.23Billion– No. of Holdings #22
Novo Holdings A/S Performance:
2026 Q1: 3.86%YTD: 3.86%2025: 16.51%
Performance for 2026 Q1 is 3.86%, and YTD is 3.86%, and 2025 is 16.51%.
About Novo Holdings A/S and 13F Hedge Fund Stock Holdings
On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, NOVO HOLDINGS A/S reported an equity portfolio of $1.2 Billions as of 31 Mar, 2026.
The top stock holdings of NOVO HOLDINGS A/S are EWTX, , ASML. The fund has invested 13.7% of it's portfolio in EDGEWISE THERAPEUTICS INC and 11.5% of portfolio in BROOKFIELD CORP.
The fund managers got completely rid off ZENAS BIOPHARMA INC, INSMED INC (INSM) and IO BIOTECH INC (IOBT) stocks. They significantly reduced their stock positions in VALNEVA SE (VALN), APOGEE THERAPEUTICS INC and ASML HOLDING N V (ASML). NOVO HOLDINGS A/S opened new stock positions in XENON PHARMACEUTICALS INC (XENE). The fund showed a lot of confidence in some stocks as they added substantially to SALESFORCE INC (CRM), BRIDGEBIO ONCOLOGY THERAPEUT and MIRUM PHARMACEUTICALS INC (MIRM).
The top stock holdings of NOVO HOLDINGS A/S are EWTX, , ASML. The fund has invested 13.7% of it's portfolio in EDGEWISE THERAPEUTICS INC and 11.5% of portfolio in BROOKFIELD CORP.
The fund managers got completely rid off ZENAS BIOPHARMA INC, INSMED INC (INSM) and IO BIOTECH INC (IOBT) stocks. They significantly reduced their stock positions in VALNEVA SE (VALN), APOGEE THERAPEUTICS INC and ASML HOLDING N V (ASML). NOVO HOLDINGS A/S opened new stock positions in XENON PHARMACEUTICALS INC (XENE). The fund showed a lot of confidence in some stocks as they added substantially to SALESFORCE INC (CRM), BRIDGEBIO ONCOLOGY THERAPEUT and MIRUM PHARMACEUTICALS INC (MIRM).
Novo Holdings A/S Equity Portfolio Value
Last Reported on: 15 May, 2026
Novo Holdings A/S Annual Return Estimates Vs S&P 500
Our best estimate is that NOVO HOLDINGS A/S made a return of 3.86% in the last quarter. In trailing 12 months, it's portfolio return was 38.92%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| xenon pharmaceuticals inc | 28,228,200 |
New stocks bought by Novo Holdings A/S
Additions
| Ticker | % Inc. |
|---|---|
| salesforce inc | 19.08 |
| bridgebio oncology therapeut | 11.45 |
| mirum pharmaceuticals inc | 4.82 |
Additions to existing portfolio by Novo Holdings A/S
Reductions
| Ticker | % Reduced |
|---|---|
| valneva se | -54.12 |
| apogee therapeutics inc | -21.05 |
| asml holding n v | -16.67 |
| viridian therapeutics inc | -15.97 |
| enliven therapeutics inc | -13.51 |
| vaxcyte inc | -6.13 |
| crinetics pharmaceuticals in | -4.62 |
Novo Holdings A/S reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| io biotech inc | -1,529,830 |
| zenas biopharma inc | -52,649,500 |
| insmed inc | -34,808,000 |
Novo Holdings A/S got rid off the above stocks
Sector Distribution
NOVO HOLDINGS A/S has about 47.4% of it's holdings in Others sector.
- Others
- Healthcare
- Technology
| Sector | % |
|---|---|
| Others | 47.4 |
| Healthcare | 46.5 |
| Technology | 6.1 |
Market Cap. Distribution
NOVO HOLDINGS A/S has about 9% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
- LARGE-CAP
- SMALL-CAP
| Category | % |
|---|---|
| UNALLOCATED | 47.4 |
| MID-CAP | 37.6 |
| LARGE-CAP | 9 |
| SMALL-CAP | 6 |
Stocks belong to which Index?
About 47.2% of the stocks held by NOVO HOLDINGS A/S either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
- S&P 500
| Index | % |
|---|---|
| Others | 52.7 |
| RUSSELL 2000 | 41.3 |
| S&P 500 | 5.9 |
Novo Holdings A/S Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Novo Holdings A/S
NOVO HOLDINGS A/S has 22 stocks in it's portfolio. About 73.9% of the portfolio is in top 10 stocks. CRM proved to be the most loss making stock for the portfolio. EWTX was the most profitable stock for NOVO HOLDINGS A/S last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ASML | asml holding n v | 10.16 | 94,946 | 125,408,000 | reduced | -16.67 | ||
| BABA | alibaba group hldg ltd | 2.62 | 257,327 | 32,284,200 | unchanged | 0.00 | ||
| BMRN | biomarin pharmaceutical inc | 3.02 | 660,000 | 37,283,400 | unchanged | 0.00 | ||
| CLDX | celldex therapeutics inc new | 3.08 | 1,200,000 | 38,064,000 | unchanged | 0.00 | ||
| CRM | salesforce inc | 5.95 | 393,187 | 73,396,200 | added | 19.08 | ||
| CRNX | crinetics pharmaceuticals in | 4.56 | 1,550,000 | 56,296,000 | reduced | -4.62 | ||
| EWTX | edgewise therapeutics inc | 13.65 | 5,350,000 | 168,525,000 | unchanged | 0.00 | ||
| FDMT | 4d molecular therapeutics in | 2.75 | 3,650,740 | 33,988,400 | unchanged | 0.00 | ||
| INSM | insmed inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| IOBT | io biotech inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MIRM | mirum pharmaceuticals inc | 9.92 | 1,325,000 | 122,404,000 | added | 4.82 | ||
| MQ | marqeta inc | 0.15 | 441,558 | 1,801,560 | unchanged | 0.00 | ||
| PCVX | vaxcyte inc | 4.05 | 860,000 | 49,974,600 | reduced | -6.13 | ||
| PHVS | pharvaris n v | 4.01 | 1,750,000 | 49,437,500 | unchanged | 0.00 | ||
| VALN | valneva se | 0.54 | 1,057,420 | 6,608,880 | reduced | -54.12 | ||
| VRDN | viridian therapeutics inc | 3.17 | 2,000,000 | 39,120,000 | reduced | -15.97 | ||
| XENE | xenon pharmaceuticals inc | 2.29 | 485,438 | 28,228,200 | new | |||
| brookfield corp | 11.46 | 3,496,240 | 141,493,000 | unchanged | 0.00 | |||
| maplight therapeutics inc | 6.07 | 3,686,620 | 74,949,000 | unchanged | 0.00 | |||
| enliven therapeutics inc | 4.07 | 1,280,000 | 50,176,000 | reduced | -13.51 | |||